Upload File

second marrow infusion for poor graft function after allogeneic marrow transplantation

  • Home
  • Documents
  • Second marrow infusion for poor graft function after allogeneic marrow transplantation
6

Upload: independent

Post on 14-Nov-2023

0 views

Category:

Documents


0 download

Report

TRANSCRIPT

Page 1: Second marrow infusion for poor graft function after allogeneic marrow transplantation
Page 2: Second marrow infusion for poor graft function after allogeneic marrow transplantation
Page 3: Second marrow infusion for poor graft function after allogeneic marrow transplantation
Page 4: Second marrow infusion for poor graft function after allogeneic marrow transplantation
Page 5: Second marrow infusion for poor graft function after allogeneic marrow transplantation
Page 6: Second marrow infusion for poor graft function after allogeneic marrow transplantation

Identifying value constellations for service infusion in SMEs

Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice

Rover-Based Visual Target Tracking Validation and Mission Infusion

Glucose-insulin infusion improves cardiac function during fetal tachycardia

Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with

Genetic susceptibility to aspergillosis in allogeneic stem-cell transplantation

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation

Adenosine Release andHighEnergyPhosphates inIntact DogHearts During Norepinephrine Infusion

Applying National Patient Safety Goals to Infusion Therapy

Allogeneic Mesenchymal Stem Cell Transplantation in Postinfarcted Rat Myocardium

‘Rejected’ vs. ‘rejecting’ transcriptomes in allogeneic challenged colonial urochordates

Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin

Allogeneic bone marrow transplantation and donor lymphocyte infusion in a mouse model of irradiation-induced myelodysplastic/myeloproliferation syndrome (MD/MPS): evidence for a graft-versus-MD/MPS

Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis

Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation

Infusion of farm mechanization technologies in Indian agriculture

Infusion of

Infusion phlebitis assessment measures: a systematic review

CDS-Depleted Donor Lymphocyte Infusion as Treatment for Relapsed Chronic Myelogenous Leukemia After Allogeneic Bone Marrow Transplantation

Lung Function, Pulmonary Complications, and Mortality after Allogeneic Blood and Marrow Transplantation in Children

Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantation

Percutaneous catheter placement for hepatic arterial infusion chemotherapy

Intracarotid substance P infusion inhibits ventilation in the goat

Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized

Catheter-Related Candidemia Caused by Candida lipolytica in a Patient Receiving Allogeneic Bone Marrow Transplantation

Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant

Smart Intravenous Infusion Dosing System - MDPI

Subcutaneous Immune Globulin Home Infusion Program

Monomer Selection for In Situ Polymerization Infusion ... - MDPI

Bone Marrow

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

An Innate Response to Allogeneic Nonself Mediated by Monocytes

Transplantation Following Bone Marrow Producing Graft-versus-Host Disease Cytomegalovirus Disease without Amotosalen Prevent Lethal Allogeneic T Cells Treated with